Fate therapeutics announces proposed public offering of common stock

Fate therapeutics announces proposed public offering of common stock.fate therapeutics - to use proceeds from offering to fund clinical trials, nonclinical studies, manufacture of clinical product candidates, others.

FATE Ratings Summary

FATE Quant Ranking